Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax

Detalles Bibliográficos
Autores principales: Lima, Keli, Vicari, Hugo Passos, Carlos, Jorge Antonio Elias Godoy, da Silva, Jean Carlos Lipreri, Figueiredo-Pontes, Lorena Lobo de, Rego, Eduardo Magalhães, Machado-Neto, João Agostinho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885367/
https://www.ncbi.nlm.nih.gov/pubmed/33753045
http://dx.doi.org/10.1016/j.htct.2021.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885367/
https://www.ncbi.nlm.nih.gov/pubmed/33753045
http://dx.doi.org/10.1016/j.htct.2021.01.004

Ejemplares similares